Literature DB >> 19844086

Prognostic value of circadian blood pressure variation in chronic kidney disease.

Rajiv Agarwal1, Shathabish S Kariyanna, Robert P Light.   

Abstract

BACKGROUND: Reduced circadian variation in blood pressure (BP) has been associated with cardiovascular morbidity, mortality and accelerated progression of kidney disease, but its independent prognostic value remains unknown.
METHODS: Using 2 definitions, one based on dipping and the other based on BP pattern (assessed by cosinor rhythmometry), we studied the prognosis of circadian BP variation among 322 patients, 179 (56%) of whom had chronic kidney disease (CKD).
RESULTS: During a follow-up period extending for up to 8.7 years, 116 (36%) patients died and 57 (32%) patients with CKD developed end-stage renal disease (ESRD). Compared to 106 patients (33%) who were dippers, the unadjusted hazard ratio (HR) for death among non-dippers was 2.03 (95% CI 1.30-3.16, p = 0.002). However, this HR became nonsignificant [1.39 (95% CI 0.89-2.19), p = 0.15] when adjusted for age and 24-hour average systolic BP. Although non-dipping was marginally associated with ESRD [HR 1.98 (95% CI 0.996-3.92), p = 0.051], even this association was weakened when adjusted for overall 24-hour systolic BP (HR 1.67, p = 0.15). Similar to the dipping definition, the BP pattern-based definition was significantly associated with mortality (p = 0.005) but not with ESRD (p = 0.68). Compared to those 'in-phase,' the HR for death among those 'out-of-phase' was 1.86 (95% CI 1.25-2.75, p = 0.002). Although this HR when adjusted for overall mean BP remained significant, when further adjusted for age, it too became nonsignificant.
CONCLUSION: Among elderly veterans with or without CKD, circadian variation in BP is associated with mortality, but not ESRD. However, after accounting for common clinical risk factors, this association of circadian BP variation with mortality or ESRD is abolished. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19844086     DOI: 10.1159/000252775

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  11 in total

Review 1.  Pharmacotherapy of Hypertension in Chronic Dialysis Patients.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 2.  Cycles, Arrows and Turbulence: Time Patterns in Renal Disease, a Path from Epidemiology to Personalized Medicine?

Authors:  Jeroen P Kooman; Len A Usvyat; Marijke J E Dekker; Dugan W Maddux; Jochen G Raimann; Frank M van der Sande; Xiaoling Ye; Yuedong Wang; Peter Kotanko
Journal:  Blood Purif       Date:  2018-11-16       Impact factor: 2.614

Review 3.  Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease?

Authors:  Rupal Mehta; Paul E Drawz
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

Review 4.  The complex relationship between CKD and ambulatory blood pressure patterns.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Adv Chronic Kidney Dis       Date:  2015-03       Impact factor: 3.620

Review 5.  Managing kidney disease with blood-pressure control.

Authors:  Elke Wühl; Franz Schaefer
Journal:  Nat Rev Nephrol       Date:  2011-06-21       Impact factor: 28.314

Review 6.  Ambulatory blood pressure in chronic kidney disease.

Authors:  Debbie L Cohen; Yonghong Huan; Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 7.  Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease.

Authors:  Fabio Angeli; Giorgio Gentile; Monica Trapasso; Paolo Verdecchia; Gianpaolo Reboldi
Journal:  J Hum Hypertens       Date:  2018-06-13       Impact factor: 3.012

8.  Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis.

Authors:  Anna Pisano; Francesca Mallamaci; Graziella D'Arrigo; Davide Bolignano; Gregoire Wuerzner; Alberto Ortiz; Michel Burnier; Nada Kanaan; Pantelis Sarafidis; Alexandre Persu; Charles J Ferro; Charalampos Loutradis; Ioannis N Boletis; Gérard London; Jean-Michel Halimi; Bénédicte Sautenet; Patrick Rossignol; Liffert Vogt; Carmine Zoccali
Journal:  Clin Kidney J       Date:  2021-09-23

Review 9.  Autonomic nerves and circadian control of renal function.

Authors:  Bryan K Becker; Dingguo Zhang; Reham Soliman; David M Pollock
Journal:  Auton Neurosci       Date:  2019-01-10       Impact factor: 3.145

Review 10.  The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?

Authors:  Rajiv Agarwal; Alberto Martinez-Castelao; Andrzej Wiecek; Ziad Massy; Gultekin Suleymanlar; Alberto Ortiz; Peter J Blankestijn; Adrian Covic; Friedo W Dekker; Kitty J Jager; Bengt Lindholm; David Goldsmith; Danilo Fliser; Gerard London; Carmine Zoccali
Journal:  Kidney Int Suppl (2011)       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.